FHLC holdings
All 340 positions of Fidelity MSCI Health Care Index ETF.
Positions
340
Top 10 weight
50.6%
Effective holdings
25.1
1 / sum of squared weights
In stocks
99.6%
In bonds
0.0%
Outside the US
3.3%
Asset mix
Sectors
97% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly & Co. | Equity | 12.13% | $346M | 370,443 | US |
| 2 | JNJJohnson & Johnson | Equity | 8.94% | $255M | 1,110,650 | US |
| 3 | ABBVABBVIE INC. | Equity | 6.03% | $172M | 814,750 | US |
| 4 | UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | Equity | 5.42% | $155M | 417,583 | US |
| 5 | MRKMerck & Co., Inc. | Equity | 4.38% | $125M | 1,144,186 | US |
| 6 | AMGNAmgen Inc | Equity | 3.01% | $86M | 248,232 | US |
| 7 | TMOThermo Fisher Scientific, Inc. | Equity | 2.91% | $83M | 173,204 | US |
| 8 | GILDGilead Sciences Inc | Equity | 2.62% | $75M | 571,936 | US |
| 9 | ISRGIntuitive Surgical Inc. | Equity | 2.62% | $75M | 163,426 | US |
| 10 | ABTAbbott Laboratories | Equity | 2.55% | $73M | 801,594 | US |
| 11 | PFEPfizer Inc. | Equity | 2.45% | $70M | 2,621,047 | US |
| 12 | BMYBristol-Myers Squibb Co. | Equity | 1.99% | $57M | 938,456 | US |
| 13 | DHRDanaher Corporation | Equity | 1.84% | $52M | 293,052 | US |
| 14 | SYKStryker Corporation | Equity | 1.75% | $50M | 158,669 | US |
| 15 | VRTXVertex Pharmaceuticals Inc | Equity | 1.75% | $50M | 116,958 | US |
| 16 | CVSCVS HEALTH CORPORATION | Equity | 1.71% | $49M | 585,200 | US |
| 17 | Medtronic PLC | Equity | 1.68% | $48M | 590,998 | IE |
| 18 | MCKMcKesson Corporation | Equity | 1.62% | $46M | 56,896 | US |
| 19 | BSXBoston Scientific Corp. | Equity | 1.38% | $39M | 683,394 | US |
| 20 | ELVElevance Health, Inc. | Equity | 1.35% | $39M | 102,444 | US |
| 21 | CIThe Cigna Group | Equity | 1.25% | $36M | 123,144 | US |
| 22 | REGNRegeneron Pharmaceuticals Inc | Equity | 1.18% | $34M | 47,616 | US |
| 23 | HCAHCA Healthcare, Inc. | Equity | 1.12% | $32M | 73,639 | US |
| 24 | CORCencora, Inc. | Equity | 0.92% | $26M | 84,961 | US |
| 25 | ZTSZOETIS INC. | Equity | 0.82% | $23M | 203,147 | US |
| 26 | EWEdwards Lifesciences Corp | Equity | 0.78% | $22M | 267,514 | US |
| 27 | CAHCardinal Health, Inc. | Equity | 0.74% | $21M | 109,528 | US |
| 28 | IDXXIdexx Laboratories Inc | Equity | 0.72% | $21M | 36,805 | US |
| 29 | BDXBecton, Dickinson and Co. | Equity | 0.69% | $20M | 131,388 | US |
| 30 | ALNYAlnylam Pharmaceuticals, Inc. | Equity | 0.66% | $19M | 60,901 | US |
| 31 | AAgilent Technologies Inc. | Equity | 0.53% | $15M | 130,688 | US |
| 32 | RMDResMed Inc. | Equity | 0.50% | $14M | 67,289 | US |
| 33 | WATWaters Corp | Equity | 0.49% | $14M | 45,335 | US |
| 34 | INSMInsmed, Inc. | Equity | 0.47% | $13M | 98,313 | US |
| 35 | HUMHumana Inc. | Equity | 0.46% | $13M | 55,439 | US |
| 36 | BIIBBiogen Inc. Common Stock | Equity | 0.45% | $13M | 67,622 | US |
| 37 | GEHCGE HealthCare Technologies Inc. Common Stock | Equity | 0.45% | $13M | 209,991 | US |
| 38 | NTRANatera, Inc. Common Stock | Equity | 0.44% | $12M | 60,581 | US |
| 39 | IQVIQVIA Holdings Inc. | Equity | 0.44% | $12M | 78,509 | US |
| 40 | CNCCentene Corporation | Equity | 0.43% | $12M | 226,652 | US |
| 41 | MTDMettler-Toledo International | Equity | 0.42% | $12M | 9,423 | US |
| 42 | VEEVVeeva Systems Inc. | Equity | 0.39% | $11M | 71,993 | US |
| 43 | UTHRUnited Therapeutics Corp | Equity | 0.38% | $11M | 18,852 | US |
| 44 | RVMDRevolution Medicines, Inc. Common Stock | Equity | 0.38% | $11M | 74,541 | US |
| 45 | DXCMDexCom, Inc. | Equity | 0.38% | $11M | 179,798 | US |
| 46 | DGXQuest Diagnostics Inc. | Equity | 0.35% | $10.0M | 51,278 | US |
| 47 | WSTWest Pharmaceutical Services, Inc. | Equity | 0.35% | $9.9M | 33,185 | US |
| 48 | STERIS PLC | Equity | 0.34% | $9.8M | 45,282 | IE |
| 49 | LHLabcorp Holdings Inc. | Equity | 0.34% | $9.8M | 38,214 | US |
| 50 | Royalty Pharma PLC | Equity | 0.33% | $9.4M | 186,793 | GB |
| 51 | ILMNIllumina Inc | Equity | 0.31% | $8.9M | 70,313 | US |
| 52 | VTRSViatris Inc. Common Stock | Equity | 0.28% | $7.9M | 530,957 | US |
| 53 | ZBHZimmer Biomet Holdings, Inc. | Equity | 0.26% | $7.5M | 91,433 | US |
| 54 | MRNAModerna, Inc. Common Stock | Equity | 0.26% | $7.4M | 162,167 | US |
| 55 | INCYIncyte Genomics Inc | Equity | 0.26% | $7.3M | 76,855 | US |
| 56 | THCTenet Healthcare Corporation New | Equity | 0.25% | $7.2M | 40,458 | US |
| 57 | State Street Global Advisors | Cash | 0.23% | $6.7M | 6,674,000 | US |
| 58 | NBIXNeurocrine Biosciences Inc | Equity | 0.21% | $6.1M | 45,968 | US |
| 59 | COOThe Cooper Companies, Inc. Common Stock | Equity | 0.20% | $5.7M | 90,338 | US |
| 60 | PENPenumbra, Inc. | Equity | 0.20% | $5.6M | 17,152 | US |
| 61 | PODDInsulet Corporation | Equity | 0.20% | $5.6M | 32,471 | US |
| 62 | ALGNAlign Technology Inc | Equity | 0.19% | $5.5M | 31,438 | US |
| 63 | IONSIonis Pharmaceuticals, Inc. Common Stock | Equity | 0.19% | $5.3M | 70,978 | US |
| 64 | EXELExelixis Inc | Equity | 0.18% | $5.2M | 117,127 | US |
| 65 | ELANElanco Animal Health Incorporated Common Stock | Equity | 0.18% | $5.1M | 229,567 | US |
| 66 | Jazz Pharmaceuticals PLC | Equity | 0.18% | $5.1M | 25,172 | IE |
| 67 | ENSGThe Ensign Group, Inc. | Equity | 0.18% | $5.0M | 26,762 | US |
| 68 | Roivant Sciences Ltd | Equity | 0.17% | $4.9M | 173,133 | BM |
| 69 | SOLVSolventum Corporation | Equity | 0.17% | $4.9M | 72,184 | US |
| 70 | BBIOBridgeBio Pharma, Inc. Common Stock | Equity | 0.17% | $4.7M | 66,688 | US |
| 71 | GMEDGLOBUS MEDICAL INC | Equity | 0.16% | $4.7M | 51,771 | US |
| 72 | EHCEncompass Health Corporation Common Stock | Equity | 0.16% | $4.6M | 46,407 | US |
| 73 | MOHMolina Healthcare, Inc. | Equity | 0.16% | $4.6M | 23,769 | US |
| 74 | RVTYRevvity, Inc. | Equity | 0.16% | $4.5M | 52,333 | US |
| 75 | BMRNBioMarin Pharmaceuticals Inc | Equity | 0.16% | $4.5M | 84,082 | US |
| 76 | GHGuardant Health, Inc. Common Stock | Equity | 0.16% | $4.5M | 51,837 | US |
| 77 | MEDPMedpace Holdings, Inc. Common Stock | Equity | 0.15% | $4.3M | 10,364 | US |
| 78 | UHSUniversal Health Services, Inc. Class B | Equity | 0.15% | $4.3M | 25,483 | US |
| 79 | BAXBaxter International Inc. | Equity | 0.15% | $4.2M | 237,837 | US |
| 80 | ARWRArrowhead Research Corporation | Equity | 0.15% | $4.2M | 56,550 | US |
| 81 | TECHBio-Techne Corp. | Equity | 0.14% | $4.0M | 71,837 | US |
| 82 | GKOSGlaukos Corporation | Equity | 0.13% | $3.8M | 26,450 | US |
| 83 | CRLCharles River Laboratories International, Inc. | Equity | 0.13% | $3.8M | 22,674 | US |
| 84 | CORCencora, Inc. | Equity | 0.13% | $3.8M | 21,108 | US |
| 85 | HSICHenry Schein Inc | Equity | 0.13% | $3.7M | 48,980 | US |
| 86 | MDGLMadrigal Pharmaceuticals, Inc. Common Stock | Equity | 0.12% | $3.5M | 6,819 | US |
| 87 | HALOHalozyme Therapeutics, Inc. | Equity | 0.12% | $3.5M | 54,463 | US |
| 88 | PRAXPraxis Precision Medicines, Inc. Common Stock | Equity | 0.12% | $3.5M | 10,867 | US |
| 89 | CYTKCytokinetics Inc. | Equity | 0.12% | $3.4M | 53,720 | US |
| 90 | AXSMAxsome Therapeutics, Inc | Equity | 0.12% | $3.3M | 16,077 | US |
| 91 | HQYHealthEquity, Inc | Equity | 0.11% | $3.2M | 39,344 | US |
| 92 | BTSGBrightSpring Health Services, Inc. Common Stock | Equity | 0.11% | $3.2M | 66,653 | US |
| 93 | PCVXVaxcyte, Inc. Common Stock | Equity | 0.11% | $3.1M | 54,160 | US |
| 94 | RGENRepligen Corp | Equity | 0.10% | $2.9M | 24,698 | US |
| 95 | DVADaVita Inc. | Equity | 0.10% | $2.8M | 17,983 | US |
| 96 | CHEChemed Corporation | Equity | 0.10% | $2.8M | 6,497 | US |
| 97 | KRYSKrystal Biotech, Inc. Common Stock | Equity | 0.09% | $2.6M | 9,976 | US |
| 98 | LNTHLantheus Holdings, Inc | Equity | 0.09% | $2.6M | 30,428 | US |
| 99 | AVTRAvantor, Inc. | Equity | 0.09% | $2.6M | 316,237 | US |
| 100 | TFXTeleflex Incorporated | Equity | 0.09% | $2.5M | 20,462 | US |
| 101 | HIMSHims & Hers Health, Inc. | Equity | 0.09% | $2.5M | 91,178 | US |
| 102 | Alkermes PLC | Equity | 0.09% | $2.4M | 72,512 | IE |
| 103 | BIOBio-Rad Laboratories, Inc.Class A | Equity | 0.08% | $2.4M | 8,563 | US |
| 104 | TEMTempus AI, Inc. Class A Common Stock | Equity | 0.08% | $2.4M | 42,918 | US |
| 105 | TGTXTG Therapeutics, Inc. | Equity | 0.08% | $2.4M | 69,640 | US |
| 106 | PTGXProtagonist Therapeutics, Inc | Equity | 0.08% | $2.3M | 23,132 | US |
| 107 | PTCTPTC Therapeutics, Inc. | Equity | 0.08% | $2.2M | 33,415 | US |
| 108 | RYTMRhythm Pharmaceuticals, Inc. Common Stock | Equity | 0.07% | $2.1M | 26,169 | US |
| 109 | LGNDLigand Pharmaceuticals Inc. | Equity | 0.07% | $2.1M | 9,071 | US |
| 110 | CRISPR Therapeutics AG | Equity | 0.07% | $2.1M | 39,353 | CH |
| 111 | XENEXenon Pharmaceuticals Inc | Equity | 0.07% | $2.0M | 36,576 | CA |
| 112 | CORTCorcept Therapeutics Inc. | Equity | 0.07% | $2.0M | 43,968 | US |
| 113 | NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share | Equity | 0.07% | $2.0M | 76,092 | US |
| 114 | IRTCiRhythm Holdings, Inc. Common Stock | Equity | 0.07% | $1.9M | 14,825 | US |
| 115 | MMSIMerit Medical Systems Inc | Equity | 0.07% | $1.9M | 27,451 | US |
| 116 | NUVLNuvalent, Inc. Class A Common Stock | Equity | 0.06% | $1.9M | 18,465 | US |
| 117 | BRKRBruker Corporation | Equity | 0.06% | $1.8M | 48,831 | US |
| 118 | INDVIndivior Pharmaceuticals, Inc. Common Stock | Equity | 0.06% | $1.8M | 48,679 | US |
| 119 | KYMRKymera Therapeutics, Inc. Common Stock | Equity | 0.06% | $1.8M | 21,910 | US |
| 120 | ALHCAlignment Healthcare, Inc. Common Stock | Equity | 0.06% | $1.7M | 77,111 | US |
| 121 | RDNTRadNet, Inc. Common Stock | Equity | 0.06% | $1.7M | 30,424 | US |
| 122 | MIRMMirum Pharmaceuticals, Inc. Common Stock | Equity | 0.06% | $1.7M | 17,493 | US |
| 123 | SYRESpyre Therapeutics, Inc. Common Stock | Equity | 0.06% | $1.7M | 22,417 | US |
| 124 | TVTXTravere Therapeutics, Inc. Common Stock | Equity | 0.06% | $1.6M | 38,888 | US |
| 125 | TWSTTwist Bioscience Corporation Common Stock | Equity | 0.06% | $1.6M | 27,593 | US |
| 126 | CRNXCrinetics Pharmaceuticals, Inc. | Equity | 0.06% | $1.6M | 41,183 | US |
| 127 | OGNOrganon & Co. | Equity | 0.05% | $1.6M | 118,299 | US |
| 128 | VKTXViking Therapeutics, Inc | Equity | 0.05% | $1.6M | 49,795 | US |
| 129 | CPRXCatalyst Pharmaceutical Inc. | Equity | 0.05% | $1.5M | 54,185 | US |
| 130 | SHCSotera Health Company Common Stock | Equity | 0.05% | $1.5M | 97,516 | US |
| 131 | LivaNova PLC | Equity | 0.05% | $1.5M | 25,135 | GB |
| 132 | TMDXTransMedics Group, Inc. Common Stock | Equity | 0.05% | $1.5M | 14,862 | US |
| 133 | BKDBrookdale Senior Living, Inc. | Equity | 0.05% | $1.5M | 103,339 | US |
| 134 | OPCHOption Care Health, Inc. Common Stock | Equity | 0.05% | $1.5M | 72,815 | US |
| 135 | APGEApogee Therapeutics, Inc. Common Stock | Equity | 0.05% | $1.5M | 17,612 | US |
| 136 | APLSApellis Pharmaceuticals, Inc. Common Stock | Equity | 0.05% | $1.4M | 35,150 | US |
| 137 | ITGRInteger Holdings Corporation | Equity | 0.05% | $1.4M | 16,022 | US |
| 138 | DOCSDoximity, Inc. | Equity | 0.05% | $1.4M | 57,862 | US |
| 139 | DNTHDianthus Therapeutics, Inc. Common Stock | Equity | 0.05% | $1.4M | 16,047 | US |
| 140 | TERNTerns Pharmaceuticals, Inc. Common Stock | Equity | 0.05% | $1.4M | 26,088 | US |
| 141 | COGTCogent Biosciences, Inc. Common Stock | Equity | 0.05% | $1.4M | 38,351 | US |
| 142 | SRRKScholar Rock Holding Corporation Common Stock | Equity | 0.05% | $1.4M | 28,968 | US |
| 143 | CGONCG Oncology, Inc. Common stock | Equity | 0.05% | $1.3M | 19,705 | US |
| 144 | HAEHaemonetics Corporation | Equity | 0.05% | $1.3M | 21,461 | US |
| 145 | BEAMBeam Therapeutics Inc. Common Stock | Equity | 0.04% | $1.3M | 42,166 | US |
| 146 | ICUIICU Medical Inc | Equity | 0.04% | $1.3M | 10,702 | US |
| 147 | SUPNSupernus Pharmaceuticals, Inc. | Equity | 0.04% | $1.3M | 26,541 | US |
| 148 | PBHPrestige Consumer Healthcare Inc. | Equity | 0.04% | $1.2M | 22,052 | US |
| 149 | ACADAcadia Pharmaceuticals Inc. | Equity | 0.04% | $1.2M | 54,956 | US |
| 150 | DNLIDenali Therapeutics Inc. Common Stock | Equity | 0.04% | $1.2M | 64,790 | US |
| 151 | CONConcentra Group Holdings Parent, Inc. | Equity | 0.04% | $1.2M | 53,425 | US |
| 152 | VCYTVeracyte, Inc. | Equity | 0.04% | $1.2M | 36,188 | US |
| 153 | ARQTArcutis Biotherapeutics, Inc. Common Stock | Equity | 0.04% | $1.2M | 50,560 | US |
| 154 | CELCCelcuity Inc. Common Stock | Equity | 0.04% | $1.2M | 9,556 | US |
| 155 | SLNOSoleno Therapeutics, Inc. Common Stock | Equity | 0.04% | $1.1M | 21,263 | US |
| 156 | IBRXImmunityBio, Inc. Common Stock | Equity | 0.04% | $1.1M | 158,131 | US |
| 157 | PRVAPrivia Health Group, Inc. Common Stock | Equity | 0.04% | $1.1M | 45,158 | US |
| 158 | WAYWaystar Holding Corp. Common Stock | Equity | 0.04% | $1.1M | 52,484 | US |
| 159 | ADMAADMA Biologics, Inc. | Equity | 0.04% | $1.1M | 109,138 | US |
| 160 | LQDALiquidia Corporation Common Stock | Equity | 0.04% | $1.1M | 28,405 | US |
| 161 | LMATLeMaitre Vascular, Inc. | Equity | 0.04% | $1.1M | 9,837 | US |
| 162 | XRAYDENTSPLY SIRONA Inc. | Equity | 0.04% | $1.1M | 91,834 | US |
| 163 | TXG10x Genomics, Inc. Class A Common Stock | Equity | 0.04% | $1.1M | 48,932 | US |
| 164 | IDYAIDEAYA Biosciences, Inc. Common Stock | Equity | 0.04% | $1.1M | 36,855 | US |
| 165 | NHCNational Healthcare Corp. | Equity | 0.04% | $1.1M | 6,169 | US |
| 166 | ACHCAcadia Healthcare Company, Inc. | Equity | 0.04% | $1.0M | 40,172 | US |
| 167 | RCUSArcus Biosciences, Inc. | Equity | 0.04% | $1.0M | 40,376 | US |
| 168 | CLDXCelldex Therapeutics, Inc | Equity | 0.04% | $1.0M | 30,973 | US |
| 169 | IMVTImmunovant, Inc. Common Stock | Equity | 0.03% | $997K | 36,741 | US |
| 170 | IMNMImmunome, Inc. | Equity | 0.03% | $986K | 42,979 | US |
| 171 | RAREUltragenyx Pharmaceutical Inc. | Equity | 0.03% | $981K | 39,736 | US |
| 172 | SRPTSarepta Therapeutics,, Inc. Common Stock | Equity | 0.03% | $951K | 45,547 | US |
| 173 | NKTRNektar Therapeutics | Equity | 0.03% | $947K | 11,131 | US |
| 174 | TARSTarsus Pharmaceuticals, Inc. Common Stock | Equity | 0.03% | $945K | 14,864 | US |
| 175 | DYNDyne Therapeutics, Inc. Common Stock | Equity | 0.03% | $943K | 53,716 | US |
| 176 | AXGNAxogen, Inc. Common Stock | Equity | 0.03% | $929K | 21,500 | US |
| 177 | AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | Equity | 0.03% | $923K | 71,718 | US |
| 178 | NEOGNeogen Corp | Equity | 0.03% | $904K | 96,177 | US |
| 179 | Kiniksa Pharmaceuticals International Plc | Equity | 0.03% | $891K | 16,563 | GB |
| 180 | MDPediatrix Medical Group, Inc. | Equity | 0.03% | $888K | 39,438 | US |
| 181 | BCRXBioCryst Pharmaceuticals Inc | Equity | 0.03% | $881K | 96,151 | US |
| 182 | GRALGRAIL, Inc. Common Stock | Equity | 0.03% | $877K | 16,096 | US |
| 183 | OMCLOmnicell Inc | Equity | 0.03% | $876K | 21,155 | US |
| 184 | SEMSELECT MEDICAL HOLDINGS CORP | Equity | 0.03% | $838K | 51,090 | US |
| 185 | ERASErasca, Inc. Common Stock | Equity | 0.03% | $832K | 78,076 | US |
| 186 | VCELVericel Corporation | Equity | 0.03% | $824K | 23,722 | US |
| 187 | ADUSAddus HomeCare Corp. | Equity | 0.03% | $819K | 8,452 | US |
| 188 | DFTXDefinium Therapeutics, Inc. Common Shares | Equity | 0.03% | $813K | 37,154 | CA |
| 189 | CRVLCorvel Corp | Equity | 0.03% | $810K | 14,092 | US |
| 190 | SNDXSyndax Pharmaceuticals, Inc. | Equity | 0.03% | $803K | 37,483 | US |
| 191 | AUPHAurinia Pharmaceuticals Inc | Equity | 0.03% | $800K | 52,025 | CA |
| 192 | CAPRCapricor Therapeutics Inc | Equity | 0.03% | $754K | 22,465 | US |
| 193 | INVAInnoviva, Inc. Common Stock | Equity | 0.03% | $749K | 32,578 | US |
| 194 | EWTXEdgewise Therapeutics, Inc. Common Stock | Equity | 0.03% | $747K | 24,144 | US |
| 195 | Perrigo Co PLC | Equity | 0.03% | $743K | 62,744 | IE |
| 196 | ADPTAdaptive Biotechnologies Corporation Common Stock | Equity | 0.03% | $738K | 52,346 | US |
| 197 | PACSPACS Group, Inc. | Equity | 0.03% | $738K | 21,995 | US |
| 198 | RLAYRelay Therapeutics, Inc. Common Stock | Equity | 0.03% | $736K | 56,820 | US |
| 199 | IRONDisc Medicine, Inc. Common Stock | Equity | 0.03% | $736K | 11,162 | US |
| 200 | ALMSAlumis Inc. Common Stock | Equity | 0.03% | $732K | 29,655 | US |
| 201 | Novocure Ltd | Equity | 0.03% | $731K | 48,035 | JE |
| 202 | INSPInspire Medical Systems, Inc. | Equity | 0.03% | $722K | 12,863 | US |
| 203 | ASTHAstrana Health Inc. Common Stock | Equity | 0.02% | $713K | 20,883 | US |
| 204 | AGIOAgios Pharmaceuticals, Inc. | Equity | 0.02% | $706K | 25,231 | US |
| 205 | RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock | Equity | 0.02% | $703K | 203,251 | US |
| 206 | ARDXArdelyx, Inc. | Equity | 0.02% | $703K | 111,086 | US |
| 207 | PGNYProgyny, Inc. Common Stock | Equity | 0.02% | $694K | 37,351 | US |
| 208 | NTLAIntellia Therapeutics, Inc | Equity | 0.02% | $684K | 50,707 | US |
| 209 | OCULOcular Therapeutix, Inc. | Equity | 0.02% | $681K | 72,719 | US |
| 210 | ORKAOruka Therapeutics, Inc. Common Stock | Equity | 0.02% | $681K | 9,959 | US |
| 211 | AORTArtivion, Inc. | Equity | 0.02% | $659K | 18,392 | US |
| 212 | ANIPANI Pharmaceuticals, Inc. | Equity | 0.02% | $651K | 8,188 | US |
| 213 | ATRCAtriCure, Inc. | Equity | 0.02% | $649K | 23,082 | US |
| 214 | UFPTUFP Technologies Inc | Equity | 0.02% | $642K | 3,350 | US |
| 215 | VERAVera Therapeutics, Inc. Class A Common Stock | Equity | 0.02% | $625K | 17,563 | US |
| 216 | TNDMTandem Diabetes Care, Inc. | Equity | 0.02% | $615K | 31,511 | US |
| 217 | ENOVEnovis Corporation | Equity | 0.02% | $615K | 26,221 | US |
| 218 | ELVNEnliven Therapeutics, Inc. Common Stock | Equity | 0.02% | $610K | 14,804 | US |
| 219 | HRMYHarmony Biosciences Holdings, Inc. Common Stock | Equity | 0.02% | $610K | 19,511 | US |
| 220 | PRCTPROCEPT BioRobotics Corporation Common Stock | Equity | 0.02% | $610K | 25,362 | US |
| 221 | LFSTLifeStance Health Group, Inc. Common Stock | Equity | 0.02% | $607K | 80,190 | US |
| 222 | Newamsterdam Pharma Co NV | Equity | 0.02% | $605K | 21,169 | NL |
| 223 | STOKStoke Therapeutics, Inc. Common Stock | Equity | 0.02% | $602K | 18,412 | US |
| 224 | HROWHarrow, Inc. Common Stock | Equity | 0.02% | $595K | 14,677 | US |
| 225 | KODKodiak Sciences Inc Common Stock | Equity | 0.02% | $579K | 13,317 | US |
| 226 | WGSGeneDx Holdings Corp. Class A Common Stock | Equity | 0.02% | $578K | 9,194 | US |
| 227 | NRIXNurix Therapeutics, Inc. Common stock | Equity | 0.02% | $578K | 34,589 | US |
| 228 | PVLAPalvella Therapeutics, Inc. Common Stock | Equity | 0.02% | $577K | 4,496 | US |
| 229 | Biohaven Ltd | Equity | 0.02% | $575K | 59,940 | VG |
| 230 | AHCOAdaptHealth Corp. Common Stock | Equity | 0.02% | $568K | 43,305 | US |
| 231 | NEONeoGenomics, Inc. | Equity | 0.02% | $561K | 60,531 | US |
| 232 | MLYSMineralys Therapeutics, Inc. Common Stock | Equity | 0.02% | $559K | 20,978 | US |
| 233 | TRVITrevi Therapeutics, Inc. Common Stock | Equity | 0.02% | $557K | 40,477 | US |
| 234 | VIRVir Biotechnology, Inc. Common Stock | Equity | 0.02% | $554K | 54,198 | US |
| 235 | Establishment Labs Holdings Inc | Equity | 0.02% | $547K | 7,971 | VG |
| 236 | ATECAlphatec Holdings, Inc. | Equity | 0.02% | $528K | 54,133 | US |
| 237 | CNMDCONMED Corporation | Equity | 0.02% | $527K | 14,369 | US |
| 238 | CLOVClover Health Investments, Corp | Equity | 0.02% | $526K | 191,101 | US |
| 239 | AVNSAvanos Medical, Inc. | Equity | 0.02% | $516K | 20,939 | US |
| 240 | PNTGThe Pennant Group, Inc. Common Stock | Equity | 0.02% | $512K | 16,336 | US |
| 241 | CDNACareDx, Inc. | Equity | 0.02% | $502K | 24,115 | US |
| 242 | NVAXNovavax Inc | Equity | 0.02% | $497K | 62,651 | US |
| 243 | PCRXPacira BioSciences, Inc. Common Stock | Equity | 0.02% | $496K | 19,461 | US |
| 244 | COLLCollegium Pharmaceutical, Inc. Common Stock | Equity | 0.02% | $495K | 14,683 | US |
| 245 | PAHCPhibro Animal Health Corporation Class A | Equity | 0.02% | $494K | 9,292 | US |
| 246 | SGRYSurgery Partners, Inc. Common Stock | Equity | 0.02% | $492K | 35,045 | US |
| 247 | TDOCTeladoc Health, Inc. | Equity | 0.02% | $491K | 81,058 | US |
| 248 | USPHUS Physical Therapy Inc | Equity | 0.02% | $488K | 6,857 | US |
| 249 | AMLXAmylyx Pharmaceuticals, Inc. Common Stock | Equity | 0.02% | $483K | 30,218 | US |
| 250 | FTREFortrea Holdings Inc. Common Stock | Equity | 0.02% | $478K | 41,583 | US |
| 251 | XERSXeris Biopharma Holdings, Inc. Common Stock | Equity | 0.02% | $478K | 78,052 | US |
| 252 | IOVAIovance Biotherapeutics, Inc. Common Stock | Equity | 0.02% | $474K | 140,923 | US |
| 253 | ZYMEZymeworks Inc. | Equity | 0.02% | $463K | 16,794 | US |
| 254 | AZTAAzenta, Inc. | Equity | 0.02% | $461K | 18,758 | US |
| 255 | NUVBNuvation Bio Inc. | Equity | 0.02% | $452K | 101,610 | US |
| 256 | RAPPRapport Therapeutics, Inc. Common Stock | Equity | 0.02% | $452K | 13,646 | US |
| 257 | EYPTEyePoint, Inc. Common Stock | Equity | 0.02% | $451K | 34,174 | US |
| 258 | BFLYButterfly Network, Inc. | Equity | 0.02% | $446K | 93,022 | US |
| 259 | TNGXTango Therapeutics, Inc. | Equity | 0.02% | $441K | 20,381 | US |
| 260 | INBXInhibrx Biosciences, Inc. Common Stock | Equity | 0.02% | $431K | 3,333 | US |
| 261 | UroGen Pharma Ltd | Equity | 0.02% | $430K | 18,033 | IL |
| 262 | ANABAnaptysBio, Inc. Common Stock | Equity | 0.01% | $422K | 6,418 | US |
| 263 | GRDNGuardian Pharmacy Services, Inc. | Equity | 0.01% | $417K | 11,248 | US |
| 264 | VRDNViridian Therapeutics, Inc. Common Stock | Equity | 0.01% | $406K | 30,128 | US |
| 265 | TSHATaysha Gene Therapies, Inc. Common Stock | Equity | 0.01% | $399K | 62,485 | US |
| 266 | BLFSBioLife Solutions Inc. | Equity | 0.01% | $393K | 18,652 | US |
| 267 | QDELQuidelOrtho Corporation Common Stock | Equity | 0.01% | $389K | 31,649 | US |
| 268 | STAAStaar Surgical Co | Equity | 0.01% | $387K | 14,691 | US |
| 269 | AMPHAmphastar Pharmaceuticals, Inc. | Equity | 0.01% | $386K | 17,560 | US |
| 270 | MNKDMannkind Corporation | Equity | 0.01% | $384K | 135,688 | US |
| 271 | HNGEHinge Health, Inc. | Equity | 0.01% | $362K | 8,122 | US |
| 272 | WaVe Life Sciences Ltd | Equity | 0.01% | $361K | 51,175 | SG |
| 273 | uniQure NV | Equity | 0.01% | $359K | 18,008 | NL |
| 274 | SDGRSchrodinger, Inc. Common Stock | Equity | 0.01% | $355K | 29,701 | US |
| 275 | GERNGeron Corp | Equity | 0.01% | $355K | 230,599 | US |
| 276 | KALVKalVista Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $353K | 13,259 | US |
| 277 | AMNAMN Healthcare Services | Equity | 0.01% | $351K | 17,137 | US |
| 278 | TLRYTilray Brands, Inc. Common Stock | Equity | 0.01% | $347K | 55,676 | US |
| 279 | CERTCertara, Inc. Common Stock | Equity | 0.01% | $342K | 55,826 | US |
| 280 | PGENPrecigen, Inc. Common Stock | Equity | 0.01% | $337K | 81,104 | US |
| 281 | CSTLCastle Biosciences, Inc. Common Stock | Equity | 0.01% | $331K | 13,531 | US |
| 282 | IRMDiRadimed Corporation | Equity | 0.01% | $321K | 3,851 | US |
| 283 | ANNXAnnexon, Inc. Common Stock | Equity | 0.01% | $321K | 54,687 | US |
| 284 | IARTIntegra LifeSciences Holdings | Equity | 0.01% | $315K | 29,902 | US |
| 285 | ATAIAtaiBeckley Inc. Common Stock | Equity | 0.01% | $315K | 75,711 | US |
| 286 | CTMXCytomX Therapeutics, Inc. | Equity | 0.01% | $313K | 74,256 | US |
| 287 | MBXMBX Biosciences, Inc. Common Stock | Equity | 0.01% | $311K | 10,305 | US |
| 288 | AVBPArriVent BioPharma, Inc. Common Stock | Equity | 0.01% | $307K | 9,868 | US |
| 289 | KURAKura Oncology, Inc. | Equity | 0.01% | $304K | 34,421 | US |
| 290 | Theravance Biopharma Inc | Equity | 0.01% | $292K | 17,422 | KY |
| 291 | HTFLHeartflow, Inc. Common Stock | Equity | 0.01% | $285K | 9,563 | US |
| 292 | BCAXBicara Therapeutics Inc. Common Stock | Equity | 0.01% | $275K | 12,760 | US |
| 293 | XNCRXencor, Inc. | Equity | 0.01% | $273K | 22,923 | US |
| 294 | GLUEMonte Rosa Therapeutics, Inc. Common Stock | Equity | 0.01% | $271K | 14,154 | US |
| 295 | ABUSArbutus Biopharma Corporation Common Stock | Equity | 0.01% | $271K | 64,437 | CA |
| 296 | CRMDCorMedix Inc. | Equity | 0.01% | $258K | 34,004 | US |
| 297 | SANASana Biotechnology, Inc. Common Stock | Equity | 0.01% | $257K | 78,026 | US |
| 298 | JANXJanux Therapeutics, Inc. Common Stock | Equity | 0.01% | $254K | 17,660 | US |
| 299 | PHRPhreesia, Inc. | Equity | 0.01% | $252K | 27,318 | US |
| 300 | OLMAOlema Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $249K | 17,308 | US |
| 301 | ARVNArvinas, Inc | Equity | 0.01% | $248K | 25,043 | US |
| 302 | PHATPhathom Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $246K | 21,971 | US |
| 303 | MLTXMoonLake Immunotherapeutics Class A Ordinary Shares | Equity | 0.01% | $239K | 14,568 | KY |
| 304 | EMBCEmbecta Corp. Common Stock | Equity | 0.01% | $233K | 25,512 | US |
| 305 | SIBNSI-BONE, Inc. Common Stock | Equity | 0.01% | $233K | 18,818 | US |
| 306 | HSTMHealthStream Inc | Equity | 0.01% | $229K | 11,039 | US |
| 307 | OPKOpko Health Inc. | Equity | 0.01% | $225K | 200,102 | US |
| 308 | TYRATyra Biosciences, Inc. Common Stock | Equity | 0.01% | $213K | 6,122 | US |
| 309 | SPRYARS Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $206K | 24,917 | US |
| 310 | NUTXNutex Health Inc. Common Stock | Equity | 0.01% | $203K | 1,700 | US |
| 311 | ORICOric Pharmaceuticals, Inc. Common Stock | Equity | 0.01% | $198K | 20,039 | US |
| 312 | MYGNMyriad Genetics Inc | Equity | 0.01% | $196K | 41,272 | US |
| 313 | Kestra Medical Technologies Ltd | Equity | 0.01% | $196K | 9,448 | BM |
| 314 | PLSEPulse Biosciences, Inc Common Stock (DE) | Equity | 0.01% | $196K | 9,245 | US |
| 315 | CGEMCullinan Therapeutics, Inc. Common Stock | Equity | 0.01% | $193K | 14,784 | US |
| 316 | MDXGMiMedx Group, Inc | Equity | 0.01% | $177K | 52,532 | US |
| 317 | SVRASavara Inc. | Equity | 0.01% | $166K | 31,710 | US |
| 318 | AVAHAveanna Healthcare Holdings Inc. Common Stock | Equity | 0.01% | $157K | 23,951 | US |
| 319 | TRAXFirst Tracks Biotherapeutics, Inc. Ordinary Shares | Equity | 0.01% | $149K | 6,418 | US |
| 320 | DNAGinkgo Bioworks Holdings, Inc. | Equity | 0.01% | $144K | 16,982 | US |
| 321 | ZBIOZenas BioPharma, Inc. Common Stock | Equity | 0.00% | $142K | 7,339 | US |
| 322 | PRMEPrime Medicine, Inc. Common Stock | Equity | 0.00% | $140K | 39,527 | US |
| 323 | PSNLPersonalis, Inc. Common Stock | Equity | 0.00% | $135K | 24,438 | US |
| 324 | FLGTFulgent Genetics, Inc. Common Stock | Equity | 0.00% | $133K | 8,753 | US |
| 325 | ARDTArdent Health, Inc. | Equity | 0.00% | $128K | 13,112 | US |
| 326 | SEPNSepterna, Inc. Common Stock | Equity | 0.00% | $122K | 5,127 | US |
| 327 | LABStandard BioTools Inc. Common Stock | Equity | 0.00% | $110K | 118,488 | US |
| 328 | UPBUpstream Bio, Inc. Common Stock | Equity | 0.00% | $102K | 11,160 | US |
| 329 | GDRXGoodRx Holdings, Inc. Class A Common Stock | Equity | 0.00% | $99K | 41,844 | US |
| 330 | CMPXCompass Therapeutics, Inc. Common Stock | Equity | 0.00% | $91K | 51,153 | US |
| 331 | LENZLENZ Therapeutics, Inc. Common Stock | Equity | 0.00% | $48K | 5,375 | US |
| 332 | Chicago Mercantile Exchange | Derivative | 0.00% | $28K | 7 | US |
| 333 | CONTRA AKOUOS INC | Equity | 0.00% | $2K | 11,863 | US |
| 334 | OABIWOmniAb, Inc. Warrant | Equity | 0.00% | $2K | 3,335 | US |
| 335 | OABIWOmniAb, Inc. Warrant | Equity | 0.00% | $1K | 3,335 | US |
| 336 | HOLXHologic Inc | Equity | 0.00% | $1K | 100,790 | US |
| 337 | ACLXArcellx, Inc. Common Stock | Equity | 0.00% | $888 | 12,690 | US |
| 338 | CVRChicago Rivet & Machine Co. | Equity | 0.00% | $0 | 24,218 | US |
| 339 | AKROAkero Therapeutics, Inc. Common Stock | Equity | 0.00% | $0 | 22,341 | US |
| 340 | Chicago Mercantile Exchange | Derivative | -0.00% | −$71K | 61 | US |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Exit | EXASExact Sciences Corp | 0.30% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | RVMDRevolution Medicines Inc | 0.21% | 0.38% | +15.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | WATWaters Corp | 0.34% | 0.49% | +65.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | RNAMAvidity Biosciences Inc | 0.12% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | FOLDAmicus Therapeutics Inc | 0.06% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | BTSGBrightSpring Health Services Inc | 0.06% | 0.11% | +49.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | TERNTerns Pharmaceuticals Inc | — | 0.05% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | DNTHDianthus Therapeutics Inc | 0.01% | 0.05% | +118.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | XENEXenon Pharmaceuticals Inc | 0.04% | 0.07% | +37.3% | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | ERASErasca Inc | — | 0.03% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | Avadel Pharmaceuticals PLC | 0.03% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | CAPRCapricor Therapeutics Inc | — | 0.03% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | ALMSAlumis Inc | — | 0.03% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | NKTRNektar Therapeutics | 0.01% | 0.03% | +49.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Exit | DVAXDynavax Technologies Corp | 0.02% | — | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| New position | KODKodiak Sciences Inc | — | 0.02% | — | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CELCCelcuity Inc | 0.02% | 0.04% | +63.1% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | APGEApogee Therapeutics Inc | 0.03% | 0.05% | +19.2% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | INDVIndivior Pharmaceuticals Inc | 0.05% | 0.06% | +21.0% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | CLDXCelldex Therapeutics Inc | 0.02% | 0.04% | +13.5% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | PVLAPalvella Therapeutics Inc | 0.01% | 0.02% | +35.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | INVAInnoviva Inc | 0.02% | 0.03% | +18.7% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | RXRXRecursion Pharmaceuticals Inc | 0.02% | 0.02% | +20.8% | Jan 31, 2026 → Apr 30, 2026 SEC |
| Increase | Biohaven Ltd | 0.02% | 0.02% | +11.9% | Jan 31, 2026 → Apr 30, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.